Nurse-led Education on Patients With Chronic Heart Failure and Their Informal Caregivers

NCT ID: NCT06545370

Last Updated: 2025-09-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

280 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-01

Study Completion Date

2027-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The current study intends to examine the influence of nurse-led education on patients with chronic heart failure and their caregivers, with the goal of optimizing care for both and improving patients\' clinical outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Introduction: Heart failure is a clinical syndrome with pandemic characteristics, and its prevalence increases with age. The development of self-care behavior by patients seems to be a crucial component for effective management and reduction of the disease\'s impact. Nurse- guided patient education has been associated with improved outcomes and the development of self-care behavior. In recent years, several studies have also focused on the contribution of informal caregivers to improving the outcomes of the disease. Nurse-led education for both patients and their caregivers has been shown to enhance their caregiving skills, leading to better disease management and beneficial outcomes.

Purpose: To investigate the impact of nurse-led education on patients with chronic heart failure and their caregivers, aiming to optimize care for both and improve the clinical outcomes of patients.

Methodology: A randomized controlled trial will be conducted with the manipulation of independent variables and the creation of a control group. Patients will be randomly assigned to three groups: a) the control group (Group A), receiving standard care based on the policies and protocols of primary health care; b) the first intervention group (Group B), receiving nurse-led education through oral sessions, educational materials, and regular phone calls; and c) the second intervention group (Group C), receiving the described nurse-led education while caregivers also undergo training through oral sessions, phone calls, and appropriately designed educational materials. Greek versions of the Minnesota Living with Heart Failure Questionnaire, Hippocratic Hypertension Self-Care Scale, and Self-Efficacy for Appropriate Medication Use Scale will be used to assess quality of life, self-care behavior, and medication adherence. For caregivers, their quality of life, caregiving burden, and sense of guilt will be evaluated using Greek versions of the EuroQol ED-5, Heart Failure Caregiver Questionnaire, and Caregiver Guilt Questionnaire, respectively. Measurements will be taken before patient and caregiver education (initial meeting), 1 month, and 6 months after the initial meeting. Statistical analysis will be performed using SPSS (version 26) and descriptive and inferential statistical analysis methods.

Expected Results: The proposed study is expected to highlight the contribution of nurse-led education in optimizing care for both patients and their caregivers. Additionally, this education is anticipated to lead to better clinical outcomes for patients with chronic heart failure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group - No Intervention Group

the control group (Group A) will receive standard care based on the policies and protocols of primary health care

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention 1 group - Patients' education

the first intervention group (Group B) will receive nurse-led education through oral sessions, educational materials, and regular phone calls

Group Type EXPERIMENTAL

Intervention 1 / Nurse-led patients' education

Intervention Type OTHER

nurse-led education through oral sessions, educational materials, and regular phone calls

Intervention 2 - Patients' and caregivers' education

the second intervention group (Group C) will receive the described nurse-led education while caregivers also undergo training through oral sessions, phone calls, and appropriately designed educational materials

Group Type EXPERIMENTAL

Intervention 1 / Nurse-led patients' education

Intervention Type OTHER

nurse-led education through oral sessions, educational materials, and regular phone calls

Intervention 2 / Nurse-led patients' & caregivers' education

Intervention Type OTHER

nurse-led education while caregivers also undergo training through oral sessions, phone calls, and appropriately designed educational materials

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intervention 1 / Nurse-led patients' education

nurse-led education through oral sessions, educational materials, and regular phone calls

Intervention Type OTHER

Intervention 2 / Nurse-led patients' & caregivers' education

nurse-led education while caregivers also undergo training through oral sessions, phone calls, and appropriately designed educational materials

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years
* Patients recently hospitalized due to the disease
* Patients and caregivers who are literate in Greek
* Patients and caregivers who provide written informed consent for their participation in the study
* Patients diagnosed with heart failure for at least 6 months
* Caregivers who have been involved in the care of the patients for at least 6 months
* Patients taking medication according to the guidelines of the European Society of Cardiology

Exclusion Criteria

* History of psychiatric disease, recent history of alcohol or/and drug abuse, dementia, and Alzheimer\'s disease (for patients and caregivers)
* Absence of an informal caregiver according to their statement
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hellenic Mediterranean University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Konstantinos Giakoumidakis

Associate Professor in Clinical Nursing - Chronic Diseases Management

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hellenic Mediterranean University

Heraklion, Crete, Greece

Site Status COMPLETED

Hellenic Mediterranean University

Heraklion, , Greece

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Greece

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Konstantinos Giakoumidakis, Associate Professor

Role: CONTACT

00306973793489

Elefteria Markaki, PhD candidate

Role: CONTACT

00306944582422

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

10/28.05.2024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Enhancing Heart Failure Self-Care
NCT00526773 COMPLETED NA